Phase 2 Smoldering Multiple Myeloma Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma (SMM)Monoclonal Gammopathy of Undetermined Significance (MGUS)
Regeneron Pharmaceuticals116 enrolled39 locationsNCT06140524
Recruiting
Phase 1Phase 2
The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital20 enrolled1 locationNCT05841550
Recruiting
Phase 2
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Multiple MyelomaSmoldering Multiple MyelomaHigh Risk Smoldering Multiple Myeloma
Irene Ghobrial, MD52 enrolled3 locationsNCT05469893
Recruiting
Phase 2
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
University of Rochester15 enrolled1 locationNCT05597345
Recruiting
Phase 2
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
High Risk Smoldering Multiple Myeloma
PETHEMA Foundation20 enrolled1 locationNCT06574126
Recruiting
Phase 2
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
Smoldering Multiple Myeloma
Stichting European Myeloma Network50 enrolled25 locationsNCT06183489
Recruiting
Phase 2
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
Prostate CancerMultiple MyelomaMonoclonal Gammopathy of Undetermined Significance+1 more
University of Rochester40 enrolled1 locationNCT04731844